| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 02/23/2006 | US20060040952 Il-8 receptor antagonists |
| 02/23/2006 | CA2577880A1 Compounds useful for inhibiting chk1 |
| 02/23/2006 | CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1626965A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders |
| 02/22/2006 | EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | CN1738796A Bis-aryl sulfonamides |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/16/2006 | WO2006016278A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 02/16/2006 | WO2005112916A3 Bis-aryl sulfonamides |
| 02/16/2006 | US20060035938 2-Pyridone derivatives as inhibitors of neutrophile elastase |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035262 Dark quenchers for donor-acceptor energy transfer |
| 02/16/2006 | CA2576407A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/16/2006 | CA2576258A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 02/15/2006 | CN1735599A 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 02/15/2006 | CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist |
| 02/15/2006 | CN1733708A Anti-hepatitis B virus tertiary amine oxide and preparation method and uses for manufacturing drug |
| 02/15/2006 | CN1242511C Electrolytic solution for secondary battery and secondary battery including the same |
| 02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | CA2180155C Naphthylamides as central nervous system agents |
| 02/09/2006 | WO2006014762A1 Substituted amide beta secretase inhibitors |
| 02/09/2006 | WO2006014405A2 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030569 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | CA2574218A1 Substituted amide beta secretase inhibitors |
| 02/09/2006 | CA2573223A1 Aromatic compound |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622618A1 Melanocortin receptor-specific compounds |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1730476A Aromatic amine ketone compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 02/08/2006 | CN1240701C 2,3,4,4-tetrahydro-1H-pyrazino (1,2-a) quinoxalin-5(6H) one deivatives being 5HT2C agonists |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995161 Central nervous system disorders |
| 02/07/2006 | US6995160 Sodium channel blockers |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/02/2006 | US20060025592 Lysine based compounds |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | CA2571424A1 Bisarylurea derivatives useful for inhibiting chk1 |
| 02/02/2006 | CA2570903A1 N-hydroxyamide derivatives and use thereof |
| 02/01/2006 | EP1620409A1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 02/01/2006 | EP1501898B1 Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | CN1729178A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 02/01/2006 | CN1239511C Novel pyrazine derivatives or salts thereof, containing the derives or the salts and intermediates for the preparation of both |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 01/31/2006 | US6992087 Substituted aryl 1,4-pyrazine derivatives |
| 01/31/2006 | US6992085 Octahydro-2H-pyrido[1,2-a]pyrazine compounds |
| 01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| 01/26/2006 | WO2006009819A1 Inhibitors of cholesteryl ester transfer protien |
| 01/26/2006 | US20060019962 Modulators of muscarinic receptors |
| 01/26/2006 | US20060019961 Estrogen receptor ligands |
| 01/26/2006 | US20060019960 Antitumoral analogs of ET-743 |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/25/2006 | EP1619188A1 Process for the preparation of monoaryl piperazines |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1446224B1 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726210A Novel compounds having selective inhibiting effect at GSK3 |
| 01/25/2006 | CN1726197A 5-substituted-pyrazine or -pyridine glucokinase activators |
| 01/25/2006 | CN1726196A Pyrazine-based tubulin inhibitors |
| 01/25/2006 | CN1238344C Method for preparing tetramethyl pyrazine |
| 01/25/2006 | CN1238337C Pesticide |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | US6989383 Method of treating cancer |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/19/2006 | DE102004023332A1 Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung Quinoxalin-2-one derivatives, useful-plant-protecting compositions containing them and processes for their preparation and their use |
| 01/19/2006 | CA2573378A1 Amide derivatives as inhibitors of histone deacetylase |
| 01/19/2006 | CA2571572A1 Mitotic kinesin inhibitors |
| 01/18/2006 | EP1616864A1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
| 01/18/2006 | EP1615931A1 Triazolopyrazines and methods of making and using the same |
| 01/18/2006 | EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 01/18/2006 | EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/12/2006 | WO2006003378A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | WO2005108378A3 Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer’s disease |